aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Fort Collins, United States, KromaTiD is dedicated to advancing the understanding of genetic abnormalities and diseases through the development of innovative molecular cytogenetics assays and reagents. The company offers a range of products including FISH probes, HD chromosome paints, and specialized kits like the TP53/CEP17 kit. Their services encompass G-band karyotyping, single-cell based assays, and whole genome assays, targeting researchers and clinicians focused on genetic research and diagnostics.
KromaTiD has made significant strides in the field of genetic analysis, with notable contributions from experts in molecular biology and genetics. The company has attracted investment from key players in the biotech industry, bolstering its research capabilities and market reach. KromaTiD's innovative assays have been instrumental in advancing genetic research, providing critical tools for identifying and understanding genetic disorders, thereby making a substantial impact on both scientific research and clinical diagnostics.
Operating Status
Active
Main Product(s)
Reagents, Assays
Technology
Biotech
Model Types
Data Information, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
United States
When was Kromatid founded?
Kromatid was founded in 2007.
Where is Kromatid’s headquarters located?
Kromatid’s headquarters is located in Fort Collins, CO, US.
When was Kromatid’s last funding round?
Kromatid’s most recent funding round was for $2M (USD) in April 2021.
How many employees does Kromatid have?
Kromatid has 33 employees as of Feb 5, 2024.
How much has Kromatid raised to-date?
As of July 05, 2023, Kromatid has raised a total of $2M (USD) since Apr 28, 2021.
Add Comparison
Total Raised to Date
$2M
USD
Last Update Apr 28, 2021
Last Deal Details
$2M
USD
Apr 28, 2021
Series Unknown
Total Employees Over Time
33
As of Feb 2024
Kromatid Address
Fort Collins,
Colorado
2017
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts